ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ADXN

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADXN
DateTimeSourceHeadlineSymbolCompany
31/01/202417:00GlobeNewswire Inc.Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.NASDAQ:ADXNAddex Therapeutics Ltd
31/01/202409:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADXNAddex Therapeutics Ltd
31/01/202408:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/01/202417:00GlobeNewswire Inc.Addex to Present at the Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
05/01/202417:30GlobeNewswire Inc.Addex to Present at Biotech Showcase™ 2024NASDAQ:ADXNAddex Therapeutics Ltd
21/12/202322:00Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
20/12/202322:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
20/12/202317:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
14/12/202322:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
14/12/202317:00GlobeNewswire Inc.Addex Creates Treasury SharesNASDAQ:ADXNAddex Therapeutics Ltd
09/12/202306:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
01/12/202308:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADXNAddex Therapeutics Ltd
30/11/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADXNAddex Therapeutics Ltd
30/11/202308:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
29/11/202322:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ADXNAddex Therapeutics Ltd
29/11/202322:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
29/11/202317:00GlobeNewswire Inc.Addex Reports Q3 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
28/11/202322:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
28/11/202317:00GlobeNewswire Inc.Addex Convenes Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
23/11/202317:00GlobeNewswire Inc.Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023NASDAQ:ADXNAddex Therapeutics Ltd
14/11/202317:00GlobeNewswire Inc.Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of PatientsNASDAQ:ADXNAddex Therapeutics Ltd
08/11/202322:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
08/11/202317:00GlobeNewswire Inc.Addex Regains Nasdaq Listing ComplianceNASDAQ:ADXNAddex Therapeutics Ltd
02/11/202317:00GlobeNewswire Inc.Addex Announces Participation in the Bio-Europe 2023 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
23/10/202321:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADXNAddex Therapeutics Ltd
20/10/202321:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
20/10/202316:00GlobeNewswire Inc.Addex Completes ADS Ratio ChangeNASDAQ:ADXNAddex Therapeutics Ltd
07/10/202307:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
07/10/202307:00GlobeNewswire Inc.Addex Announces Plan to Implement ADS Ratio ChangeNASDAQ:ADXNAddex Therapeutics Ltd
20/09/202320:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ADXN
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com